Peter H Boeijinga
Affiliation: Centre Hospitalier
- Planning of pharmacodynamic trials: I. Specificity and possible solutions. II. Stability considerations under placebo and interpretation of drug effects on EEGP H Boeijinga
FORENAP, Institute for Research in Neurosciences and Psychiatry, Rouffach, France
Methods Find Exp Clin Pharmacol 24:17-26. 2002..Classification of drug-induced changes in cerebral activity at this stage forms a useful decision instrument in planning the long-term clinical scenario of drug development (Phases II and higher)...
- Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinenceP H Boeijinga
FORENAP Research Institute for Neuroscience, Pharmacology and Psychiatry, Rouffach, France
Neuropsychobiology 50:71-7. 2004....
- Linear inverse solutions: simulations from a realistic head model in MEGLaurent Soufflet
FORENAP Institute for Research in Neuroscience, Neuropharmacology and Psychiatry, Centre Hospitalier, 68250 Rouffach, France
Brain Topogr 18:87-99. 2005..Nevertheless, no solution was able to combine at the same time a correct localization of single sources and the capability to visualize multiple sources with comparable amplitudes on the brain electromagnetic tomographies...
- Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in manPeter H Boeijinga
FORENAP FRP Institute for Research in Neuroscience, Neuropharmacology and Psychiatry, Rouffach, France corrected
J Psychopharmacol 21:321-37. 2007..001). Intermediate effects have been observed when the dose was lowered to 0.081 mg/kg. The present results have shown that ketamine may induce a psychotic-like clinical state associated with gating deficits in healthy subjects...